Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICStandard

IOPIDINE

APRACLONIDINE HYDROCHLORIDE

Standard Dose
EQ 1% BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview IOPIDINE is listed in Drugs@FDA under application 019779 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient APRACLONIDINE HYDROCHLORIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 1% BASE Sponsor HARROW EYE Submission history Latest submission status date: 2026-03-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview IOPIDINE is listed in Drugs@FDA under application 019779 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient APRACLONIDINE HYDROCHLORIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 1% BASE Sponsor HARROW EYE Submission history Latest submission status date: 2026-03-18 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.